［1］ZAIDI H,KARAKATSANIS N.Towards enhanced PET quantification in clinical oncology［J］.The British Journal of Radiology,2018,91(1081):20170508.
［2］FURLOW B.PET-CT cancer imaging［J］.Radiologic Technology,2018,90(2):149ct-170ct.
［3］DEVRIESE J,BEELS L,MAES A,et al.Review of clinically accessible methods to determine lean body mass for normalization of standardized uptake values［J］.Q J Nucl Med Mol Imaging,2016,60(1):1-11
［4］徐悦，吕涛，赵翊含，等.18F-FDG PET/CT动态显像诊断原发性肝癌的价值［J］.现代肿瘤医学,2023,31(19):3653-3657.
XU Y,LYU T,ZHAO YH,et al.Value of 18F-FDG PET/CT dynamic imaging in diagnosis of primary liver cancer［J］.Modern Oncology,2023,31(19):3653-3657.
［5］LAMMERTSMA AA.Forward to the past:The case for quantitative PET imaging［J］.J Nucl Med,2017,58(7):1019-1024.
［6］张利亚.肺癌全身动态18F-FDG PET/CT Patlak多参数成像特点及以不同输入函数重建对定量参数影响的研究［D］.合肥：安徽医科大学,2023.
ZHANG LY.Characteristics of whole-body dynamic 18F-FDG PET/CT Patlak multi-parameter imaging of lung cancer and the effect of reconstruction with different input functions on quantitative parameters［D］.Hefei:Anhui Medical University,2023.
［7］FAHRNI G,KARAKATSANIS NA,DI DG,et al.Does whole-body Patlak (18)F-FDG PET imaging improve lesion detectability in clinical oncology［J］.Eur Radiol,2019,29(9):4812-4821.
［8］SHARMA A,METE UK,SOOD A,et al.Utility of early dynamic and delayed post-diuretic (18)F-FDG PET/CT SUV(max) in predicting tumour grade and T-stage of urinary bladder carcinoma:Rsults from a prospective single centre study［J］.The British Journal of Radiology,2017,90(1072):20160787.
［9］NAKAJIMA R,ABEK,KONDO T,et al.Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma［J］.Eur Radiol,2016,26(6):1852-1862.
［10］MALINEN E,RODA LJ,KNUDTSEN IS,et al.Spatiotemporal analysis of tumor uptake patterns in dynamic (18)FDG-PET and dynamic contrast enhanced CT［J］.Acta Oncol,2011,50(6):873-882.
［11］童丽榕.肝脏肿瘤_18_F_FDG_PET_CT灌注显像参数研究［D］.昆明：昆明理工大学,2019.
TONG LR.Study on the parameters of liver tumor_18_F_FDG_PET_CT perfusion imaging［D］.Kunming：Kunming University of Science and Technology,2019.
［12］AHN SJ,PARK MS,KIM KA,et al.18F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma:A preliminary study［J］.PLoS One,2013,8(8):e71571.
［13］王绍波.18F-FDG PET/CT早期动态显像在肝癌诊断中的临床应用［D］.广州：南方医科大学,2015.
WANG SB.Clinical application of 18F-FDG PET/CT early dynamic imaging in the diagnosis of liver cancer［D］.Guangzhou:Southern Medical University,2015.
［14］WANG YY,WANG K,XU ZY,et al.High-resolution dynamic imaging and quantitative analysis of lung cancer xenografts in nude mice using clinical PET/CT［J］.Oncotarget,2017,8(32):52802-52812.
［15］MULLANI NA,HERBST RS,O' NEIL RG,et al.Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake:A comparison with 15O-labeled water-measured blood flow［J］.J Nucl Med,2008,49(4):517-523.
［16］YOUNG P,APPEL L,TOLF A,et al.Image-derived input functions from dynamic 15O-water PET scans using penalised reconstruction［J］.EJNMMI Phys,2023,10(1):15.
［17］SANGER PW,FREESMEYER M.Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in patients with hepatic metastases of neuroendocrine tumors［J］.Clinical Nuclear Medicine,2016,41(6):447-453.
［18］BRAUNE A,HOFHEINZ F,BLUTH T,et al.Comparison of static and dynamic (18)F-FDG PET/CT for quantification of pulmonary inflammation in acute lung injury［J］.J Nucl Med,2019,60(11):1629-1634.
［19］DIMITRAKOPOULOU-STRAUSS A,PAN L,SACHPEKIDIS C,et al.Kinetic modeling and parametric imaging with dynamic PET for oncological applications:General considerations,current clinical applications,and future perspectives［J］.Eur J Nucl Med Mol Imaging,2020,48(1):21-39.
［20］KAJARY K,LENGYEL Z,TOKES AM,et al.Dynamic FDG-PET/CT in the initial staging of primary breast cancer:Clinicopathological correlations［J］.Pathol Oncol Res,2020,26(2):997-1006.
［21］SOKOLOFF L,REIVICH M,KENNEDY C,et al.The ［14C］deoxyglucose method for the measurement of local cerebral glucose utilization:Theory,procedure,and normal values in the conscious and anesthetized albino rat［J］.Journal of Neurochemistry,1977,28(5):897-916.
［22］PATLAK CS,BLASBERY RG,FENSRERMACHER JD,et al.Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data［J］.J Cereb Blood Flow Metab,1983,3(1):1-7.
［23］HUANG HM.Kernel-based curve-fitting method with spatial regularization for generation of parametric images in dynamic PET［J］.Physics in Medicine and Biology,2020,65(22):225006.
［24］ANGELIS GI,FULLER OK,GILLAM JE,et al.Denoising non-steady state dynamic PET data using a feed-forward neural network［J］.Physics in Medicine and Biology,2021,66(3):034001.
［25］HASHIMOTO F,OHBA H,OTE K,et al.4D deep image prior:Dynamic PET image denoising using an unsupervised four-dimensional branch convolutional neural network［J］.Physics in Medicine and Biology,2021,66(1):015006.
［26］SILVESTRI E,SCOLOZZI V,RIZZO G,et al.The kinetics of (18)F-FDG in lung cancer:Compartmental models and voxel analysis［J］.EJNMMI Research,2018,8(1):88.
［27］PHELPS ME,HUANG SC,HOFFMAN EJ,et al.Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose:Validation of method［J］.Annals of Neurology,1979,6(5):371-388.
［28］ZAKER N,KOTASIDIS F,GARIBOTTO V,et al.Assessment of lesion detectability in dynamic whole-body PET imaging using compartmental and Patlak parametric mapping［J］.Clinical Nuclear Medicine,2020,45(5):e221-e231.
［29］PATLAK CS,BLASBERG RG.Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.Generalizations［J］.J Cereb Blood Flow Metab,1985,5(4):584-590.
［30］CHEN DL,CHERIYAN J,CHILVERS ER,et al.Quantification of lung PET images:Challenges and opportunities［J］.J Nucl Med,2017,58(2):201-207.
［31］GALLI G,INDOVINA L,CALCAGNI ML,et al.The quantification with FDG as seen by a physician［J］.Nuclear Medicine and Biology,2013,40(6):720-730.
［32］LAFFON E,CALCAGNI ML,GALLI G,et al.Comparison of three-parameter kinetic model analysis to standard Patlak's analysis in (18)F-FDG PET imaging of lung cancer patients［J］.EJNMMI Research,2018,8(1):24.
［33］IKOMA Y,WATABE H,SHIDAHARA M,et al.PET kinetic analysis:Error consideration of quantitative analysis in dynamic studies［J］.Annals of Nuclear Medicine,2008,22(1):1-11.
［34］WANG H,MIAO Y,YU W,et al.Improved clinical workflow for whole-body Patlak parametric imaging using two short dynamic acquisitions［J］.Front Oncol,2022,4(28):822708.
［35］KARAKATSANIS NA,CASEY ME,LODGE MA,et al.Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation-maximization reconstruction［J］.Physics in Medicine and Biology,2016,61(15):5456-5485.
［36］RAHMIM A,LODGEM A,KARAKATSANIS NA,et al.Dynamic whole-body PET imaging:Principles,potentials and applications［J］.Eur J Nucl Med Mol Imaging,2019,46(2):501-518.
［37］DIAS AH,PEDERSEN MF,DANIELSEN H,et al.Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction:Evaluation of 103 dynamic whole-body (18)F-FDG PET/CT scans［J］.Eur J Nucl Med Mol Imaging,2021,48(3):837-850.
［38］ZHUANG M,KARAKATSANIS NA,DIERCKX R,et al.Quantitative analysis of heterogeneous ［(18)F］FDG static(SUV) vs.Patlak(Ki) whole-body PET imaging using different segmentation methods:A simulation study［J］.Mol Imaging Biol,2019,21(2):317-327.
［39］GREUTER HN,BOELLAARD R,VAN LA,et al.Measurement of 18F-FDG concentrations in blood samples:Comparison of direct calibration and standard solution methods［J］.Journal of Nuclear Medicine Technology,2003,31(4):206-209.
［40］OHTAKE T,KOSAKA N,WATANABE T,et al.Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs［J］.J Nucl Med,1991,32(7):1432-1438.
［41］LI F,HICKS JW,YU L,et al.Plasma radio-metabolite analysis of PET tracers for dynamic PET imaging:TLC and autoradiography［J］.EJNMMI Research,2020,10(1):141.
［42］MEIJER TWH,DE GEUS-OEI LF,VISSER EP,et al.Tumor delineation and quantitative assessment of glucose metabolic rate within histologic subtypes of non-small cell lung cancer by using dynamic (18)F fluorodeoxyglucose PET［J］.Radiology,2017,283(2):547-559.
［43］KRAMER GM,FRINGS V,HOETJES N,et al.Repeatability of quantitative whole-body 18F-FDG PET/CT uptake measures as function of uptake interval and lesion selection in non-small cell lung cancer patients［J］.J Nucl Med,2016,57(9):1343-1349.
［44］HUISMAN MC,NIEMEIJER AN,WINDHORST AD,et al.Quantification of PD-L1 expression with (18)F-BMS-986192 PET/CT in patients with advanced-stage non-small cell lung cancer［J］.J Nucl Med,2020,61(10):1455-1460.
［45］HUANG YE,LU HI,LIU FY,et al.Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease［J］.Journal of Radiation Research,2012,53(2):306-312.
［46］YE Q,WU J,LU Y,et al.Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static (18)F-FDG PET as a function of injected dose［J］.Physics in Medicine and Biology,2018,63(17):175015.
［47］YANG Z,ZAN Y,ZHENG X,et al.Dynamic FDG-PET imaging to differentiate malignancies from inflammation in subcutaneous and in situ mouse model for non-small cell lung carcinoma(NSCLC)［J］.PLoS One,2015,10(9):e0139089.
［48］YAMANAKA M,SHINYA T,OTOMI Y,et al.Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer:A prospective study［J］.Nuclear Medicine Communications,2020,41(11):1189-1198.
［49］WEISSINGER M,ATMANSPACHER M,SPENGLER W,et al.Diagnostic performance of dynamic whole-body Patlak ［18F］FDG-PET/CT in patients with indeterminate lung lesions and lymph nodes［J］.J Clin Med,2023,12(12):3942.
［50］孙艺珊.早期动态18F-FDG PET/CT显像对非小细胞肺癌及FDG高代谢淋巴结的诊断价值［D］.沈阳:中国医科大学,2023.
SUN YS.The diagnostic value of early dynamic 18F-FDG PET/CT imaging in non-small cell lung cancer and FDG high metabolic lymph nodes［D］.Shenyang:China Medical University,2023.
［51］SUN Y,XIAO L,WANG Y,et al.Diagnostic value of dynamic 18F-FDG PET/CT imaging in non-small cell lung cancer and FDG hypermetabolic lymph nodes［J］.Quant Imaging Med Surg,2023,13(4):2556-2567.
［52］SHINYA T,OTOMI Y,KUBO M,et al.Preliminary clinical assessment of dynamic (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer:A prospective study［J］.Annals of Nuclear Medicine,2019,33(6):414-423.
［53］SUBRAMANIAN DR,JENKINS L,EDGAR R,et al.Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography［J］.Am J Respir Crit Care Med,2012,186(11):1125-1132.
［54］BELLANI G,MESSA C,GUERRA L,et al.Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions:A ［18F］-fluoro-2-deoxy-D-glucose PET/CT study［J］.Critical Care Medicine,2009,37(7):2216-2222.
［55］SCHERER PM,CHEN DL.Imaging pulmonary inflammation［J］.J Nucl Med,2016,57(11):1764-1770.
［56］DITTRICH AS,WINKLER T,WELLMAN T,et al.Modeling 18F-FDG kinetics during acute lung injury:Experimental data and estimation errors［J］.PLoS One,2012,7(10):e47588.
［57］DIMITRAKOPOULOU-STRAUSS A,HOFFMANN M,BERGNER R,et al.Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-［F-18］fluoro-D-glucose-positron emission tomography:A feasibility study［J］.Mol Imaging Biol,2007,9(5):308-317.
［58］YANG DM,PALMA D,LOUIE A,et al.Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer:A prospective quantitative hybrid (18)F-fluorodeoxyglucose-positron emission tomography and CT perfusion study［J］.Journal of Medical Imaging and Radiation Oncology,2019,63(1):94-101.
［59］YANG DM,PALMA DA,KWAN K,et al.Predicting pathological complete response(pCR) after stereotactic ablative radiation therapy(SABR) of lung cancer using quantitative dynamic ［(18)F］FDG PET and CT perfusion:A prospective exploratory clinical study［J］.Radiation Oncology(London,England),2021,16(1):11.
［60］GRECCHI E,VERONESE M,MORESCO RM,et al.Quantification of dynamic ［18F］FDG Pet studies in acute lung injury［J］.Mol Imaging Biol,2016,18(1):143-152.
［61］WANG D,QIU B,LIU Q,et al.Patlak-Ki derived from ultra-high sensitivity dynamic total body ［18F］FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients［J］.Eur J Nucl Med Mol Imaging,2023,50(11):3400-3413.
［62］ORDONEZ AA,WANG H,MAGOMBEDZE G,et al.Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions［J］.Nat Med,2020,26(4):529-534.
［63］SAMIMI R,KAMALI-ASL A,GERAMIFAR P,et al.Short-duration dynamic FDG PET imaging:Optimization and clinical application［J］.Physica Medica(PM),2020,80:193-200.
［64］CHEN Z,CHENG Z,DUAN Y,et al.Accurate total-body Ki parametric imaging with shortened dynamic 18F-FDG PET scan durations via effective data processing［J］.Med Phys,2023,50(4):2121-2134.
［65］GU F,WU Q.Quantitation of dynamic total-body PET imaging:Recent developments and future perspectives［J］.Eur J Nucl Med Mol Imaging,2023,50(12):3538-3557.